---
title: "Patrizia Cavazzoni's FDA to Pfizer Move Epitomizes Regulatory Capture"
date: 2025-01-15
importance: 9
draft: false

tags:
  - regulatory-capture
  - pharmaceutical-industry
  - fda
  - revolving-door
  - institutional-corruption
  - healthcare-policy
  - executive-transitions

actors:
  - Patrizia Cavazzoni
  - FDA
  - Pfizer
  - Robert F. Kennedy Jr.
  - Center for Drug Evaluation and Research
  - Diana Zuckerman
  - Public Citizen's Health Research Group

location: "Washington, D.C."
verification_status: "pending"
last_updated: 2025-10-18T00:46:43Z
---

Dr. Patrizia Cavazzoni, former head of the FDA's Center for Drug Evaluation and Research (CDER), immediately transitioned to Pfizer as chief medical officer, reigniting intense debate about the pharmaceutical industry's regulatory influence and the problematic 'revolving door' between government agencies and private corporations.

## Sources

1. [Pfizer Hires FDA Drug Regulator Cavazzoni, Sparking Revolving Door Debate](https://www.center4research.org/pfizer-hires-fda-cavazzoni-sparking-debate/)
2. [Top FDA Drug Regulator Returns to Pfizer: The Revolving Door Must End](https://www.citizen.org/news/top-fda-drug-regulator-returns-to-pfizer-the-revolving-door-must-end/)
3. [Patrizia Cavazzoni, Former Head of FDA's Drug Center, Joins Pfizer](https://www.statnews.com/2025/02/24/patrizia-cavazzoni-fda-pfizer-chief-medical-officer/)

---

**Last Updated**: October 18, 2025
**Importance Score**: 9/10
